Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Johnson & Johnson (NY: JNJ ) 163.20 -0.96 (-0.58%) Streaming Delayed Price Updated: 12:30 PM EDT, Sep 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,448,315 Open 164.40 Bid (Size) 163.19 (3) Ask (Size) 163.21 (2) Prev. Close 164.16 Today's Range 162.79 - 164.50 52wk Range 143.13 - 168.85 Shares Outstanding 2,628,679,824 Dividend Yield 2.92% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Why NYSE:JNJ provides a good dividend, while having solid fundamentals. Today 9:50 EDT Exploring JOHNSON & JOHNSON (NYSE:JNJ)'s dividend characteristics. Via Chartmill Is Johnson & Johnson Stock a Buy? September 21, 2024 This healthcare blue chip is making all the right moves to reward shareholders. Via The Motley Fool Performance YTD +2.02% +2.02% 1 Month -0.57% -0.57% 3 Month +9.44% +9.44% 6 Month +5.14% +5.14% 1 Year +1.83% +1.83% More News Read More Attorneys Vow to Oppose J&J’s Third Bankruptcy Attempt September 20, 2024 From Beasley Allen Law Firm Via Business Wire Johnson & Johnson Announces that its Subsidiary, Red River Talc LLC, has Filed a Voluntary Prepackaged Chapter 11 Case to Resolve All Current and Future Ovarian Cancer Talc Claims September 20, 2024 From Johnson & Johnson Via Business Wire Johnson & Johnson's Rybrevant Scores Third FDA-Approval Of 2024 For Certain Type Of Inoperable Lung Cancer In Pretreated Patients September 20, 2024 Via Benzinga Exposures Product Safety The Latest Analyst Ratings For Johnson & Johnson September 19, 2024 Via Benzinga Unpacking the Latest Options Trading Trends in Johnson & Johnson September 12, 2024 Via Benzinga Competitor Analysis: Evaluating Johnson & Johnson And Competitors In Pharmaceuticals Industry September 12, 2024 Via Benzinga Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease September 20, 2024 Via Benzinga Exposures Product Safety 2024 Election: Drug Prices Remain A 'Hot Topic.' Can Pharma Stocks Withstand The Pressure? September 19, 2024 Via Investor's Business Daily 2 Vanguard Index Funds Could Turn $400 Per Month Into $16,800 in Annual Dividend Income by Retirement September 19, 2024 Via The Motley Fool Chinese Biotech BeiGene Labeled 'Unique Investment' As Analyst Confident In Lead Cancer Drug September 18, 2024 Via Benzinga Top 3 Dividend Stocks to Beat Market Volatility and Boost Returns September 17, 2024 Via MarketBeat Topics Economy Exposures Economy Interest Rates Time To Invest And Or Trade In Bio-Tech Stocks? September 13, 2024 Via Talk Markets Topics ETFs Should You Buy Novavax Stock After This Regulatory Win? September 13, 2024 Via The Motley Fool How To Earn $500 A Month From Johnson & Johnson Stock September 12, 2024 Via Benzinga Metals in Tampons: FDA Initiates New Safety Measures and Testing September 11, 2024 Via Benzinga Exposures Product Safety Sony Music-Universal Music JV Hits Johnson & Johnson With Copyright Lawsuit Over Unlicensed Music Use Covering 80 Videos September 11, 2024 Via Benzinga Topics Lawsuit Exposures Financial Legal Johnson & Johnson's Mid-Stage Lung Cancer Trial Reveals Fewer Infusion-Related Reactions September 11, 2024 Via Benzinga 3 Safe Stocks with Safe Dividends for Your Portfolio September 11, 2024 Via MarketBeat Topics Economy Exposures Economy Is Hims & Hers Health the Next Teladoc? September 11, 2024 Via The Motley Fool Exposures COVID-19 2 Stocks That Are Passive Income Machines to Buy and Hold Forever September 11, 2024 Via The Motley Fool Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines September 10, 2024 Via Benzinga Kenvue Set To Pop Like A Tylenol Gelcap? Golden Cross Looms On Stock Chart September 10, 2024 Via Benzinga Dell, CoStar, PayPal And A Major Health Care Stock On CNBC's 'Final Trades' September 06, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
